A decrease in product sales from fewer eXplore Optix systems sold in North America led to reduced revenues for Canadian optical molecular imaging developer ART Advanced Research Technologies in 2006.
Revenues in 2006 were $3.1 million (U.S.), compared with $4.1 million in 2005. The net loss for 2006 was $8.7 million, compared with $13.1 million in 2005.
In the fourth quarter (end-December 31), revenues were $629,000, compared with $1.2 million in the fourth quarter of 2005. Net income was $1.4 million, compared with a net loss of $3.3 million for the three-month period ended December 31, 2005.
By AuntMinnie.com staff writers
March 26, 2007
Related Reading
ART lands CE Mark, February 8, 2007
ART, GE extend eXplore Optix pact, December 22, 2006
ART gets Health Canada approval for SoftScan, December 14, 2006
ART completes financing, corporate reorganization, November 29, 2006
ART repurchases debentures, November 21, 2006
Copyright © 2007 AuntMinnie.com
